Traditionally, chronic inflammation, hyperinsulinemia, and activation of the insulin-like growth factor-1 (IGF-1) signaling pathway have been considered to link diabetes and pancreatic cancer (8–12). This evidence concerns the gene IGF1 and Hyperinsulinemia.